Trials / Unknown
UnknownNCT04758806
Fecal Microbial Transplantation in Severe Alcoholic Hepatitis
Fecal Microbial Transplantation for Corticosteroids Non-responders and Non-eligible Patients With Severe Alcoholic Hepatitis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
1. A subtype of Alcoholic hepatitis (AH), named severe alcoholic hepatitis (SAH) is associated with high short-term mortality (J Hepatol, 2019) 2. The only SAH treatment option - corticosteroids (CS) - are often contraindicated or ineffective (STOPAH Trial) 3. New treatment modalities for remaining patients are much needed 4. Fecal microbial transplantation (FMT) is one of the promising therapies 5. Investigators aimed to see if FMT improves survival in patients admitted with SAH, not responding to-, or non-eligible for CS.
Detailed description
* FMT via upper GI tract is provided to CS non-responders (NR) or non-eligible (NE) adult patients hospitalized with SAH (determined by the Lille-model). * Modified version of the Sarin FMT protocol is used with microbiota material procured from unrelated healthy donors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Fecal microbial transplantation | Procured faeces procured from unrelated donor |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2021-12-30
- Completion
- 2022-12-30
- First posted
- 2021-02-17
- Last updated
- 2022-08-03
Locations
1 site across 1 country: Slovakia
Source: ClinicalTrials.gov record NCT04758806. Inclusion in this directory is not an endorsement.